PGHL — Procter & Gamble Health Balance Sheet
0.000.00%
- IN₹94.83bn
- IN₹91.94bn
- IN₹9.34bn
- 90
- 18
- 89
- 77
Annual balance sheet for Procter & Gamble Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,689 | 3,269 | 4,476 | 2,519 | 1,821 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,376 | 1,579 | 2,012 | 1,451 | 2,221 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,271 | 6,080 | 7,961 | 5,242 | 5,264 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,400 | 1,496 | 1,733 | 1,315 | 1,220 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 9,862 | 8,881 | 11,012 | 7,944 | 7,942 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,390 | 2,319 | 3,039 | 2,189 | 2,153 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,825 | 2,716 | 3,503 | 2,561 | 2,572 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 7,037 | 6,165 | 7,509 | 5,382 | 5,370 |
| Total Liabilities & Shareholders' Equity | 9,862 | 8,881 | 11,012 | 7,944 | 7,942 |
| Total Common Shares Outstanding |